BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 30390593)

  • 1. Protective effects of dioscin against systemic inflammatory response syndromevia adjusting TLR2/MyD88/NF‑κb signal pathway.
    Zhao X; Yin L; Fang L; Xu L; Sun P; Xu M; Liu K; Peng J
    Int Immunopharmacol; 2018 Dec; 65():458-469. PubMed ID: 30390593
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dioscin reduces lipopolysaccharide-induced inflammatory liver injury via regulating TLR4/MyD88 signal pathway.
    Yao H; Hu C; Yin L; Tao X; Xu L; Qi Y; Han X; Xu Y; Zhao Y; Wang C; Peng J
    Int Immunopharmacol; 2016 Jul; 36():132-141. PubMed ID: 27135544
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dioscin alleviates lipopolysaccharide-induced inflammatory kidney injury via the microRNA let-7i/TLR4/MyD88 signaling pathway.
    Qi M; Yin L; Xu L; Tao X; Qi Y; Han X; Wang C; Xu Y; Sun H; Liu K; Peng J
    Pharmacol Res; 2016 Sep; 111():509-522. PubMed ID: 27431331
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dioscin alleviates dimethylnitrosamine-induced acute liver injury through regulating apoptosis, oxidative stress and inflammation.
    Zhang W; Yin L; Tao X; Xu L; Zheng L; Han X; Xu Y; Wang C; Peng J
    Environ Toxicol Pharmacol; 2016 Jul; 45():193-201. PubMed ID: 27317992
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protective effects of dioscin against doxorubicin-induced nephrotoxicity via adjusting FXR-mediated oxidative stress and inflammation.
    Zhang Y; Xu Y; Qi Y; Xu L; Song S; Yin L; Tao X; Zhen Y; Han X; Ma X; Liu K; Peng J
    Toxicology; 2017 Mar; 378():53-64. PubMed ID: 28082111
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protective effects of Dioscin against sepsis-induced cardiomyopathy via regulation of toll-like receptor 4/MyD88/p65 signal pathway.
    Zhang M; Zhi D; Liu P; Wang Y; Duan M
    Immun Inflamm Dis; 2024 May; 12(5):e1229. PubMed ID: 38775678
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dioscin alleviates alcoholic liver fibrosis by attenuating hepatic stellate cell activation via the TLR4/MyD88/NF-κB signaling pathway.
    Liu M; Xu Y; Han X; Yin L; Xu L; Qi Y; Zhao Y; Liu K; Peng J
    Sci Rep; 2015 Dec; 5():18038. PubMed ID: 26655640
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dioscin inhibits ischemic stroke‑induced inflammation through inhibition of the TLR4/MyD88/NF‑κB signaling pathway in a rat model.
    Zhu S; Tang S; Su F
    Mol Med Rep; 2018 Jan; 17(1):660-666. PubMed ID: 29115455
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protective effect of dioscin against thioacetamide-induced acute liver injury via FXR/AMPK signaling pathway in vivo.
    Zheng L; Yin L; Xu L; Qi Y; Li H; Xu Y; Han X; Liu K; Peng J
    Biomed Pharmacother; 2018 Jan; 97():481-488. PubMed ID: 29091898
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dioscin attenuates renal ischemia/reperfusion injury by inhibiting the TLR4/MyD88 signaling pathway via up-regulation of HSP70.
    Qi M; Zheng L; Qi Y; Han X; Xu Y; Xu L; Yin L; Wang C; Zhao Y; Sun H; Liu K; Peng J
    Pharmacol Res; 2015 Oct; 100():341-52. PubMed ID: 26348276
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dioscin prevents LPS‑induced acute lung injury through inhibiting the TLR4/MyD88 signaling pathway via upregulation of HSP70.
    Zeng H; Yang L; Zhang X; Chen Y; Cai J
    Mol Med Rep; 2018 May; 17(5):6752-6758. PubMed ID: 29512786
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dioscin ameliorates cerebral ischemia/reperfusion injury through the downregulation of TLR4 signaling via HMGB-1 inhibition.
    Tao X; Sun X; Yin L; Han X; Xu L; Qi Y; Xu Y; Li H; Lin Y; Liu K; Peng J
    Free Radic Biol Med; 2015 Jul; 84():103-115. PubMed ID: 25772012
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HMGB1 mediates Aspergillus fumigatus-induced inflammatory response in alveolar macrophages of COPD mice via activating MyD88/NF-κB and syk/PI3K signalings.
    Zhang P; Xin X; Fang L; Jiang H; Xu X; Su X; Shi Y
    Int Immunopharmacol; 2017 Dec; 53():125-132. PubMed ID: 29078091
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effect of hypothermia on TLR2/MyD88 signal pathway in lung tissue in rats with acute lung injury induced by lipopolysaccharide].
    Lai J; Tang Z; Hu J; Zhou W; Zhang C; Chen X
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2014 Nov; 26(11):815-20. PubMed ID: 25399897
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protective Effects of Dioscin against Lipopolysaccharide-Induced Acute Lung Injury through Inhibition of Oxidative Stress and Inflammation.
    Yao H; Sun Y; Song S; Qi Y; Tao X; Xu L; Yin L; Han X; Xu Y; Li H; Sun H; Peng J
    Front Pharmacol; 2017; 8():120. PubMed ID: 28377715
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of dioscin on promoting liver regeneration via activating Notch1/Jagged1 signal pathway.
    Xu L; Gu L; Tao X; Xu Y; Qi Y; Yin L; Han X; Peng J
    Phytomedicine; 2018 Jan; 38():107-117. PubMed ID: 29425642
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protective effects of dioscin against fructose-induced renal damage via adjusting Sirt3-mediated oxidative stress, fibrosis, lipid metabolism and inflammation.
    Qiao Y; Xu L; Tao X; Yin L; Qi Y; Xu Y; Han X; Tang Z; Ma X; Liu K; Peng J
    Toxicol Lett; 2018 Mar; 284():37-45. PubMed ID: 29197622
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diosgenin Attenuates Lipopolysaccharide-Induced Parkinson's Disease by Inhibiting the TLR/NF-κB Pathway.
    Li B; Xu P; Wu S; Jiang Z; Huang Z; Li Q; Chen D
    J Alzheimers Dis; 2018; 64(3):943-955. PubMed ID: 29966203
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Paeoniflorin inhibits high glucose-induced macrophage activation through TLR2-dependent signal pathways.
    Shao YX; Xu XX; Li YY; Qi XM; Wang K; Wu YG; Meng XM
    J Ethnopharmacol; 2016 Dec; 193():377-386. PubMed ID: 27566204
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The protective effect of dexmedetomidine on LPS-induced acute lung injury through the HMGB1-mediated TLR4/NF-κB and PI3K/Akt/mTOR pathways.
    Meng L; Li L; Lu S; Li K; Su Z; Wang Y; Fan X; Li X; Zhao G
    Mol Immunol; 2018 Feb; 94():7-17. PubMed ID: 29241031
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.